No more blood shortages

Israel’s RedC Biotech is developing a process for mass-production of red blood cells for transfusions. Working with Accellta, a spin-off startup from Israel’s Technion Institute, they use stem cells from O-negative donors to mass-produce red blood cells for most humans, even without testing.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.